Text Module


Share

Program Content

Activities

  • DLL3 in SCLC: Module
    Class in Session: DLL3 as a Therapeutic Target in Small-Cell Lung Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 12, 2023

    Expires: April 11, 2024

Provided by

ProCE Banner

Supporters

This activity is supported by educational funding provided by

Amgen